PEDIATRICS Vol. 118 No. 3 September 2006, pp. 1133-1139 (doi:10.1542/peds.2006-0655)
ARTICLE |
Prognostic Factors for Early Severity in a Childhood Multiple Sclerosis Cohort
a Service de Neurologie Pédiatrique, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, INSERM U802, Paris, France
b Division of Clinical Epidemiology, McGill University and Royal Victoria Hospital, Montreal, Canada
OBJECTIVE. The goal was to identify prognostic factors for an early severe course in a cohort of patients with childhood-onset multiple sclerosis, for the construction of a predictive tool.
METHODS. The cohort consisted of 197 children from the French Kid Sclérose en Plaques neuropediatric cohort with relapsing/remitting multiple sclerosis beginning before the age of 16 years. Patients were included from 1990 to 2003. We used multivariate survival analysis (Cox model) to evaluate the prognostic value of clinical, MRI, and biological covariates at onset for the occurrence of a third attack or severe disability ("severity" outcome).
RESULTS. The cohort was monitored for a mean of 5.5 ± 3.6 years. The "severity" outcome was recorded for 144 patients (73%). The risk of severity was higher for girls, for a time between the first and second attacks of <1 year, for childhood-onset multiple sclerosis MRI criteria at onset, for an absence of severe mental state changes at onset, and for a progressive course. A derived childhood-onset multiple sclerosis potential index for early severity was found to have a positive predictive value for severity of >35% for the upper 2 quartiles.
CONCLUSIONS. The clinical and MRI prognostic factors for early severity that were identified were used as the basis of a predictive tool, which will be validated in another cohort. This tool should make it possible to identify subgroups at risk of early severe disease and should facilitate therapeutic studies.
Key Words: children multiple sclerosis cohort multivariate analysis survival analysis
Abbreviations: A1first attack A2second attack A3third attack MSmultiple sclerosis DSSdisability status scale
Accepted May 5, 2006.
This article has been cited by other articles:
![]() |
Y. Mikaeloff, G. Caridade, M. Rossier, S. Suissa, and M. Tardieu Hepatitis B Vaccination and the Risk of Childhood-Onset Multiple Sclerosis Arch Pediatr Adolesc Med, December 1, 2007; 161(12): 1176 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mikaeloff, G. Caridade, M. Tardieu, S. Suissa, and on behalf of the KIDSEP study group Parental smoking at home and the risk of childhood-onset multiple sclerosis in children Brain, October 1, 2007; 130(10): 2589 - 2595. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Renoux, S. Vukusic, Y. Mikaeloff, G. Edan, M. Clanet, B. Dubois, M. Debouverie, B. Brochet, C. Lebrun-Frenay, J. Pelletier, et al. Natural History of Multiple Sclerosis with Childhood Onset N. Engl. J. Med., June 21, 2007; 356(25): 2603 - 2613. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Krupp and D. P. Hertz Pediatric multiple sclerosis: Conference Report overview Neurology, April 17, 2007; 68(16_suppl_2): S1 - S2. [Full Text] [PDF] |
||||
![]() |
Y. Mikaeloff, G. Caridade, S. Assi, M. Tardieu, S. Suissa, and on behalf of the KIDSEP study group of the French Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination Brain, April 1, 2007; 130(4): 1105 - 1110. [Abstract] [Full Text] [PDF] |
||||








